Axol Bioscience- Human iPSCs Derived Cells

About AXOL

Axol has over 60 different patient disease lines in stock. If you want to reliably model diseases like Alzheimer’s, Parkinson’s or ALS using human iPSC-derived cells in a dish, contact with Bio-Science Ltd. to see which lines have the genetic backgrounds and Isogenic controls to suit your needs. Axol provides fully defined differentiated cells from these disease lines.

"Like you, we believe that having more human-relevant disease models will expand scientific knowledge and de-risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models.
We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety.
When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier-stage modeling and safety testing and laterstage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development."

Products:

axoCells™

Our market-leading iPSCs are trusted by customers across the world. Our commitment to quality extends beyond our R&D and manufacturing process to our logistics, supply and customer
support teams. We work to not only provide you with our high-quality cells in the shortest time possible, but to also support you in their use. 

All the cells listed in this section are ready-to-ship along with protocol information and supporting data, which are all readily available:

• Cortical Neurons
• Motor Neurons
• Sensory Neurons
• Cardiomyocytes
• Microglia
• Astrocytes
• Culture Media & Reagents

axoLines™

Differentiated cells from our disease lines are developed on request. Our patient lines enable you to successfully model diseases in a dish. Our hope is that using our cells in mono and co-culture will help our customers develop better understanding, assays and therapies, for these diseases. As we continue to develop our disease model offering, new lines will quickly be added to this list.

• Amyotrophic Lateral Sclerosis
• Friedreich’s Ataxia
• Huntington’s Disease
• Alzheimer’s Disease & Neuroinflammation
• Parkinson’s Disease

axoServices™

Axol offers custom research services. Our expert scientists and project managers have exceptional skills in complex cell biology, specializing in human neurodegenerative, neuroinflammatory and inflammatory disease models and assay development projects.

• Reprogramming 
• Differentiation 
• Gene Editing 
• Cellular Assays

For more information please visit Axol Bioscience page:  Human iPSCs for better human disease models.